Shandong Boan Biotechnology Company., LimitedHKEX: 6955

Voluntary announcement licensing of dulaglutide injection in the U.S.

· Issued by Shandong Boan Biotechnology Company., Limited via HKEXnews

Filed with HKEX · · 2 pages · English

Summary by 6ix AI

The agreement includes upfront payments, milestone payments, and sales-based commissions for the company. The company plans to leverage its partner's strengths in R&D and sales to enhance market presence.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Shandong Boan Biotechnology Company., Limited on 6ix

Later from Shandong Boan Biotechnology

All Shandong Boan Biotechnology news releases